Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · IEX Real-Time Price · USD
3.06
+0.11 (3.73%)
At close:
May 26, 2023, 4:00 PM
3.00
-0.06 (-1.96%)
After-hours:
May 26, 2023, 7:36 PM EDT
Nuwellis Market Cap
Nuwellis has a market cap or net worth of $3.69 million as of May 30, 2023. Its market cap has decreased by -38.45% in one year.
Market Cap
3.69M
Enterprise Value
-7.47M
1-Year Change
-38.45%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since February 16, 2012, Nuwellis's market cap has decreased from $75.60M to $3.69M, a decrease of -95.11%. That is a compound annual growth rate of -23.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 26, 2023 | 3.70M | 2.78% |
May 25, 2023 | 3.60M | - |
May 24, 2023 | 3.60M | 2.86% |
May 23, 2023 | 3.50M | - |
May 22, 2023 | 3.50M | -2.78% |
May 19, 2023 | 3.60M | -2.70% |
May 18, 2023 | 3.70M | 2.78% |
May 17, 2023 | 3.60M | 5.88% |
May 16, 2023 | 3.40M | 3.03% |
May 15, 2023 | 3.30M | - |
May 12, 2023 | 3.30M | -13.16% |
May 11, 2023 | 3.80M | - |
May 10, 2023 | 3.80M | -2.56% |
May 9, 2023 | 3.90M | -27.78% |
May 8, 2023 | 5.40M | - |
May 5, 2023 | 5.40M | - |
May 4, 2023 | 5.40M | 1.89% |
May 3, 2023 | 5.30M | -5.36% |
May 2, 2023 | 5.60M | -3.45% |
May 1, 2023 | 5.80M | -1.69% |
Apr 28, 2023 | 5.90M | -6.35% |
Apr 27, 2023 | 6.30M | 14.55% |
Apr 26, 2023 | 5.50M | 1.85% |
Apr 25, 2023 | 5.40M | -3.57% |
Apr 24, 2023 | 5.60M | 7.69% |
View and export this data all the way back to 2012.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Acorda Therapeutics, Inc. | 14.47M |
China Jo-Jo Drugstores, Inc. | 13.77M |
Avenue Therapeutics, Inc. | 8.79M |
Quoin Pharmaceuticals, Ltd. | 5.08M |
SciSparc Ltd. | 4.35M |
InVivo Therapeutics Holdings Corp. | 3.96M |
Dermata Therapeutics, Inc. | 3.79M |
First Wave BioPharma, Inc. | 3.65M |
Agile Therapeutics, Inc. | 3.60M |